McPartland R J, Kupfer D J, Coble P, Shaw D H, Spiker D G
Biol Psychiatry. 1979 Oct;14(5):767-76.
The REM sleep of 23 nonpsychotic patients with primary depression was studied by means of an automated REM analyzer during a drug-free period and again during amitriptyline administration. Initial drug administration (50 mg) was associated with an immediate reduction in the number, average frequency, and average size of the rapid eye movements. The average REM size remained suppressed with continued drug administration while the average REM frequency showed a rebound which was responsible for a partial recovery of the number of REMs and total REM intensity to predrug levels. With regard to individual REM periods, REM frequency and REM intensity were redistributed during tricyclic administration so that the second REM period became more "intense" than the first REM period. This automated REM analysis technique provides an objective set of measures for characterizing discrete aspects of REM sleep during a depressive episode and for evaluating the changes in REM sleep during psychotropic trials.
在无药物期以及服用阿米替林期间,通过自动快速眼动分析仪对23名患有原发性抑郁症的非精神病患者的快速眼动睡眠进行了研究。最初给药(50毫克)与快速眼动次数、平均频率和平均大小立即减少有关。随着持续给药,平均快速眼动大小仍受到抑制,而平均快速眼动频率出现反弹,这导致快速眼动次数和总快速眼动强度部分恢复到给药前水平。关于单个快速眼动期,在三环类药物给药期间,快速眼动频率和快速眼动强度重新分布,使得第二个快速眼动期比第一个快速眼动期更“强烈”。这种自动快速眼动分析技术为表征抑郁发作期间快速眼动睡眠的离散方面以及评估精神药物试验期间快速眼动睡眠的变化提供了一套客观的测量方法。